FDA Clearance Tracker · P100044-S012
INTERSECT ENT PROPEL MINI SINUS IMPLANT
Last checked: Nov 20, 2026Latest source record: Jan 31, 2014 (this decision)Source: openFDAMethods & limitations
Decided
Jan 31, 2014
Approved
Time to decision
123 days
Received Sep 30, 2013. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P100044-S012
- Device name
- INTERSECT ENT PROPEL MINI SINUS IMPLANT
- Applicant
- Intersect Ent.
- Applicant location
- Menlo Park, CA
- Received
- Sep 30, 2013
- Decided
- Jan 31, 2014
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P100044
Device type
- Device type
- Drug-eluting sinus stent (OWO)
- Device class
- Class III
- Specialty
- Otolaryngology (ENT)
FDA's approval statement
As written in FDA's record.
APPROVAL TO REVISE THE RELEASE RATE SPECIFICATION.
Source documents
Other decisions for Intersect Ent.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- VenSure LightGuide510(k)
K212774 · Decided Feb 4, 2022 · 156 days after receipt
Device type: Instrument, Ent Manual Surgical (LRC) · Otolaryngology (ENT)
- PROPEL CONTOUR SINUS IMPLANTPMA supplement
P100044-S023 · Decided Feb 23, 2017 · 206 days after receipt · Panel Track
Device type: Drug-eluting sinus stent (OWO) · Otolaryngology (ENT)
- PROPEL MINI SINUS IMPLANTPMA supplement
P100044-S018 · Decided Mar 23, 2016 · 180 days after receipt · Panel Track
Device type: Drug-eluting sinus stent (OWO) · Otolaryngology (ENT)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.